Gene sequencing firm announced plans on Monday to buy cancer screening startup in a cash-and-stock deal worth $8 billion.
Subscribe to the ºìÌÒÊÓƵ Daily
Grail (Nasdaq: GRAL) was founded in 2016 by San Diego-based Illumina as a separate company and had raised about $2 billion, with investors including Amazon’s Jeff Bezos and  co-founder Bill Gates. The deal comes weeks after Grail filed to go public.
Illumina (Nasdaq: ILMN) is Grail’s largest shareholder, holding a 14.5 percent stake. Grail stockholders, including Illumina, will receive $3.5 billion in cash and $4.5 billion in shares of Illumina stock, on Monday.
Illustration: .
Stay up to date with recent funding rounds, acquisitions, and more with the ºìÌÒÊÓƵ Daily.
![Cybersecurity illustration with shield, books, laptop. [Dom Guzman]](/wp-content/uploads/Cybersecurity_Shield-470x352.jpg)
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers